share_log

Shanghai General Healthy Information and Technology's (SHSE:605186) Problems Go Beyond Weak Profit

Shanghai General Healthy Information and Technology's (SHSE:605186) Problems Go Beyond Weak Profit

上海通用健康信息與技術(SHSE: 605186)的問題不僅限於利潤疲軟
Simply Wall St ·  05/06 02:34

Shanghai General Healthy Information and Technology Co., Ltd.'s (SHSE:605186) recent weak earnings report didn't cause a big stock movement. However, we believe that investors should be aware of some underlying factors which may be of concern.

上海康健信息技術有限公司's(上海證券交易所代碼:605186)最近疲軟的收益報告並未導致股市大幅波動。但是,我們認爲,投資者應注意一些可能令人擔憂的潛在因素。

earnings-and-revenue-history
SHSE:605186 Earnings and Revenue History May 6th 2024
SHSE: 605186 收益和收入歷史記錄 2024 年 5 月 6 日

The Impact Of Unusual Items On Profit

不尋常物品對利潤的影響

For anyone who wants to understand Shanghai General Healthy Information and Technology's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥7.3m worth of unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. Which is hardly surprising, given the name. If Shanghai General Healthy Information and Technology doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

對於任何想了解上海健健信息技術有限公司超出法定數字的利潤的人來說,值得注意的是,在過去的十二個月中,從價值730萬元人民幣的不尋常物品中獲得了法定利潤。我們不能否認更高的利潤通常會讓我們感到樂觀,但如果利潤是可持續的,我們更願意這樣做。當我們計算數千家上市公司的數字時,我們發現,特定年份中不尋常的項目所帶來的提振通常不會在第二年重演。考慮到這個名字,這並不奇怪。如果上海康健信息技術有限公司不認爲這一貢獻重演,那麼在其他條件相同的情況下,我們預計其本年度的利潤將下降。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Shanghai General Healthy Information and Technology's Profit Performance

我們對上海康健信息科技盈利表現的看法

Arguably, Shanghai General Healthy Information and Technology's statutory earnings have been distorted by unusual items boosting profit. Because of this, we think that it may be that Shanghai General Healthy Information and Technology's statutory profits are better than its underlying earnings power. Sadly, its EPS was down over the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. For example - Shanghai General Healthy Information and Technology has 1 warning sign we think you should be aware of.

可以說,提高利潤的不尋常項目扭曲了上海康健信息科技的法定收益。因此,我們認爲上海康健信息科技的法定利潤可能好於其基礎盈利能力。不幸的是,在過去的十二個月中,其每股收益有所下降。歸根結底,如果你想正確地了解公司,必須考慮的不僅僅是上述因素。有鑑於此,如果你想對公司進行更多分析,了解所涉及的風險至關重要。例如,上海健康信息技術協會有 1 個警告標誌,我們認爲您應該注意。

This note has only looked at a single factor that sheds light on the nature of Shanghai General Healthy Information and Technology's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

這份報告只研究了揭示上海康健信息技術公司利潤性質的單一因素。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論